HALO
Halozyme Therapeutics Inc
109.90$
+2.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | 46.9 | 40.9 | 31.8 | 57.4 | – | – | – | – | – | – | – | 173.6 | 48.0 | 38.0 | 29.3 | 14.6 | 14.4 | 13.0 | 17.1 | 26.1 | 39.0 | 29.0 | 20.6 | 20.2 | 17.2 | 16.5 | 20.1 | 19.0 | 13.9 | 16.6 | 11.6 | 15.1 | 25.0 | 22.8 | 22.9 | |
| 9.7 | 8.7 | 12.5 | 12.8 | 15.0 | 9.3 | 8.8 | 7.6 | 9.3 | 13.9 | 13.3 | 13.8 | 11.2 | 12.7 | 15.0 | 20.5 | 18.7 | 23.2 | 18.7 | 16.2 | 12.9 | 13.1 | 12.0 | 12.8 | 9.5 | 11.9 | 7.5 | 6.2 | 6.6 | 5.8 | 6.1 | 7.8 | 7.9 | 6.1 | 7.5 | 5.5 | 7.2 | 5.7 | 5.3 | 5.7 | |
| – | – | – | 29.5 | 34.4 | 14.2 | 10.5 | 9.5 | 10.9 | 8.5 | 9.1 | 9.6 | 9.2 | 27.2 | 42.5 | 35.1 | 37.7 | 41.0 | 91.6 | 56.0 | 21.2 | 29.4 | 21.7 | 21.3 | 56.8 | 46.4 | 80.0 | 31.9 | 20.6 | 57.9 | 29.5 | 23.4 | 16.4 | 17.0 | 16.8 | 19.4 | 17.8 | 162.2 | 36.1 | 66.1 | |
| 10.6 | 9.7 | 13.8 | 13.5 | 15.3 | 9.4 | 9.1 | 7.9 | 9.6 | 14.3 | 13.6 | 13.8 | 11.2 | 14.2 | 16.8 | 21.9 | 20.4 | 24.1 | 19.8 | 17.3 | 13.7 | 14.8 | 13.6 | 15.2 | 11.8 | 13.9 | 9.5 | 7.9 | 8.2 | 7.6 | 7.7 | 9.3 | 9.3 | 7.5 | 8.7 | 6.7 | 8.1 | 7.1 | 6.5 | 6.9 | |
| – | – | – | – | – | 35.6 | 32.4 | 26.4 | 42.0 | – | – | – | – | – | – | – | 92.0 | 42.1 | 35.8 | 29.0 | 22.7 | 25.3 | 21.0 | 28.9 | 23.6 | 29.0 | 21.2 | 15.8 | 15.7 | 13.9 | 13.3 | 15.6 | 15.1 | 11.5 | 13.4 | 10.0 | 11.9 | 17.3 | 15.7 | 16.1 | |
| – | – | – | – | – | 22.3 | 21.1 | 18.6 | 28.8 | – | – | – | – | – | – | – | – | 117.0 | 53.4 | 44.8 | 22.5 | 19.5 | 19.6 | 21.6 | 23.2 | 33.5 | 20.0 | 16.5 | 14.5 | 13.0 | 12.4 | 16.6 | 19.0 | 13.2 | 16.3 | 11.9 | 14.9 | 12.3 | 11.9 | 11.8 | |
| -3.5% | -4.2% | -3.7% | -3.8% | -1.4% | 4.5% | 4.7% | 5.4% | 3.5% | -2.6% | -1.5% | -1.7% | -2.4% | -3.6% | -3.6% | -1.6% | -0.6% | 0.9% | 1.9% | 2.2% | 4.4% | 5.1% | 5.1% | 4.6% | 4.3% | 3.0% | 5.0% | 6.1% | 6.9% | 7.7% | 8.1% | 6.0% | 5.3% | 7.6% | 6.1% | 8.4% | 6.7% | 8.1% | 8.4% | 8.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 79.0% | 77.4% | 75.3% | 75.8% | 80.9% | 90.2% | 91.6% | 93.8% | 95.7% | 93.3% | 93.4% | 93.0% | 83.0% | 76.8% | 71.6% | 72.0% | 83.1% | 83.8% | 83.2% | 82.3% | 81.4% | 81.6% | 83.2% | 81.5% | 79.5% | 78.9% | 77.5% | 77.4% | 76.7% | 76.8% | 76.4% | 75.9% | 78.3% | 80.8% | 80.2% | 81.2% | 80.3% | 78.1% | 76.9% | 78.2% | |
| -34.5% | -56.7% | -70.7% | -73.3% | -40.7% | 25.6% | 26.7% | 28.2% | 20.2% | -45.7% | -24.0% | -20.1% | -17.6% | -34.5% | -44.9% | -16.8% | 17.3% | 53.9% | 59.8% | 63.4% | 64.1% | 62.2% | 63.8% | 49.6% | 43.0% | 40.5% | 34.8% | 39.6% | 39.8% | 40.7% | 44.0% | 46.0% | 50.4% | 54.3% | 55.1% | 57.9% | 59.3% | 58.4% | 57.0% | 56.8% | |
| -44.6% | -70.2% | -86.8% | -89.4% | -53.2% | 19.9% | 21.5% | 23.9% | 16.2% | -52.9% | -28.7% | -23.5% | -19.7% | -36.9% | -48.7% | -22.0% | 10.8% | 48.2% | 49.2% | 55.4% | 88.4% | 90.8% | 92.2% | 75.1% | 36.4% | 30.6% | 25.8% | 30.2% | 32.5% | 34.0% | 36.9% | 38.6% | 41.4% | 43.7% | 44.8% | 47.3% | 47.9% | 22.7% | 23.1% | 24.9% | |
| -33.9% | -36.5% | -46.3% | -48.6% | -21.6% | 41.9% | 41.6% | 40.8% | 32.3% | -35.7% | -20.5% | -23.8% | -27.1% | -45.6% | -54.2% | -33.3% | -11.8% | 19.8% | 35.0% | 36.2% | 57.2% | 67.2% | 60.9% | 59.5% | 40.9% | 35.6% | 37.4% | 37.8% | 45.3% | 45.0% | 49.1% | 46.8% | 41.5% | 46.1% | 45.7% | 45.9% | 48.5% | 46.2% | 44.3% | 48.5% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | -206.3% | -122.0% | 30.2% | 25.8% | 29.9% | 19.1% | -32.3% | -19.6% | -16.5% | -16.3% | -78.7% | -138.1% | -37.6% | 21.7% | 85.5% | 241.3% | 191.0% | 145.2% | 204.5% | 167.1% | 124.9% | 217.7% | 119.0% | 275.8% | 154.7% | 101.9% | 336.0% | 179.3% | 116.5% | 86.7% | 122.1% | 100.6% | 167.5% | 118.2% | 649.2% | 158.8% | 288.1% | |
| -25.2% | -39.4% | -51.2% | -34.8% | -24.7% | 12.1% | 13.8% | 16.1% | 10.3% | -18.2% | -11.9% | -10.2% | -10.8% | -12.8% | -16.3% | -7.5% | 4.1% | 22.3% | 16.9% | 22.3% | 34.5% | 36.5% | 37.4% | 20.6% | 11.3% | 11.0% | 10.7% | 12.9% | 13.4% | 16.2% | 17.3% | 17.1% | 18.5% | 21.5% | 22.1% | 27.1% | 26.8% | 12.5% | 13.1% | 16.0% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 151 | 150 | 169 | 96 | 42 | 34 | 87 | 111 | 91 | 68 | 45 | 18 | 4.6 | 282 | 285 | 256 | 328 | 250 | 374 | 428 | 384 | 758 | 760 | 1,155 | 1,357 | 1,272 | 1,432 | 1,308 | 1,256 | 1,413 | 1,368 | 1,345 | 1,350 | 1,390 | 1,331 | 1,447 | 1,091 | 2,009 | 1,835 | 1,984 | |
| – | – | – | – | – | 0.4 | 1.0 | 1.2 | 1.4 | – | – | – | – | – | – | – | 7.4 | 1.6 | 2.0 | 1.7 | 1.4 | 2.9 | 2.5 | 4.5 | 4.7 | 4.0 | 4.5 | 3.4 | 3.1 | 3.1 | 2.8 | 2.6 | 2.3 | 2.1 | 1.9 | 1.8 | 1.3 | 3.5 | 2.9 | 2.8 | |
| -4.2% | -12.4% | -25.8% | 16.9% | 20.3% | 40.1% | 53.5% | 53.7% | 53.9% | 56.5% | 60.6% | 62.2% | 66.2% | 16.2% | 11.8% | 20.0% | 18.9% | 26.0% | 7.0% | 11.7% | 23.8% | 17.8% | 22.4% | 16.5% | 5.2% | 9.2% | 3.9% | 8.3% | 13.2% | 4.8% | 9.7% | 14.7% | 21.4% | 17.6% | 22.0% | 16.2% | 22.7% | 1.9% | 8.2% | 5.6% | |
| – | – | – | 3.6 | 2.9 | 1.0 | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | 0.3 | 0.3 | 4.4 | 6.7 | 3.7 | 4.0 | 2.6 | 12.9 | 7.3 | 3.1 | 4.5 | 3.4 | 4.3 | 15.5 | 8.9 | 23.2 | 10.1 | 6.1 | 18.3 | 8.6 | 5.3 | 3.3 | 4.1 | 3.1 | 4.5 | 3.0 | 43.9 | 9.8 | 15.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.56 | -0.80 | -0.90 | -0.90 | -0.62 | 0.43 | 0.48 | 0.53 | 0.32 | -0.56 | -0.35 | -0.29 | -0.27 | -0.51 | -0.58 | -0.29 | 0.15 | 0.89 | 1.10 | 1.55 | 2.79 | 2.79 | 3.08 | 2.57 | 1.52 | 1.46 | 1.32 | 1.75 | 1.89 | 2.15 | 2.47 | 2.61 | 3.02 | 3.43 | 3.83 | 4.49 | 4.87 | 2.69 | 2.84 | 3.41 | |
| 1.25 | 1.14 | 1.04 | 1.00 | 1.16 | 2.17 | 2.23 | 2.22 | 1.95 | 1.05 | 1.21 | 1.25 | 1.39 | 1.39 | 1.20 | 1.31 | 1.40 | 1.84 | 2.23 | 2.79 | 3.16 | 3.07 | 3.34 | 3.43 | 4.17 | 4.76 | 5.11 | 5.79 | 5.82 | 6.33 | 6.70 | 6.76 | 7.28 | 7.84 | 8.56 | 9.49 | 10.16 | 11.87 | 12.28 | 13.73 | |
| -0.09 | -0.25 | -0.45 | 0.43 | 0.51 | 1.43 | 1.86 | 1.78 | 1.67 | 1.73 | 1.76 | 1.79 | 1.68 | 0.65 | 0.42 | 0.76 | 0.70 | 1.04 | 0.46 | 0.81 | 1.92 | 1.37 | 1.84 | 2.06 | 0.70 | 1.23 | 0.48 | 1.13 | 1.86 | 0.64 | 1.38 | 2.24 | 3.48 | 2.81 | 3.81 | 2.68 | 4.12 | 0.41 | 1.79 | 1.18 | |
| -0.42 | -0.42 | -0.48 | -0.49 | -0.25 | 0.91 | 0.93 | 0.91 | 0.63 | -0.38 | -0.25 | -0.30 | -0.38 | -0.63 | -0.65 | -0.44 | -0.17 | 0.36 | 0.78 | 1.01 | 1.81 | 2.07 | 2.03 | 2.04 | 1.70 | 1.70 | 1.91 | 2.19 | 2.64 | 2.85 | 3.29 | 3.16 | 3.02 | 3.62 | 3.91 | 4.35 | 4.92 | 5.48 | 5.43 | 6.65 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.